← FDA Drug Approvals (Drugs@FDA)
AFATINIB
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN PHARMACEUTICALS INC · Approved 2026-02-18
Drug application
- FDA Application #
ANDA210804- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- AFATINIB
- Generic name
- Afatinib
- Active ingredients
- AFATINIB
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- MSN PHARMACEUTICALS INC
- First approval
- 2026-02-18
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown